- Tytuł:
- Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
- Autorzy:
- Źródło:
- In The Lancet Oncology December 2022 23(12):1558-1570
Czasopismo naukowe